Citizens JMP Reiterates Market Outperform Rating on STERIS (STE)
Tweet Send to a Friend
Citizens JMP analyst David Turkaly reiterated a Market Outperform rating and $265.00 price target on STERIS (NYSE: STE).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
